He, R., Li, L., Liu, L., Ma, Y., Fan, S., Liu, L., . . . Xian, X. (2023). Ceftriaxone improves impairments in synaptic plasticity and cognitive behavior in APP/PS1 mouse model of Alzheimer's disease by inhibiting extrasynaptic NMDAR‐STEP61 signaling. Journal of neurochemistry, 166(2), 215-232. https://doi.org/10.1111/jnc.15874
Citace podle Chicago (17th ed.)He, Ruo‐Bing, Li Li, Li‐Zhe Liu, Ya‐Jun Ma, Shu‐Juan Fan, Li‐Rong Liu, Wen‐Bin Li, a Xiao‐Hui Xian. "Ceftriaxone Improves Impairments in Synaptic Plasticity and Cognitive Behavior in APP/PS1 Mouse Model of Alzheimer's Disease by Inhibiting Extrasynaptic NMDAR‐STEP61 Signaling." Journal of Neurochemistry 166, no. 2 (2023): 215-232. https://doi.org/10.1111/jnc.15874.
Citace podle MLA (9th ed.)He, Ruo‐Bing, et al. "Ceftriaxone Improves Impairments in Synaptic Plasticity and Cognitive Behavior in APP/PS1 Mouse Model of Alzheimer's Disease by Inhibiting Extrasynaptic NMDAR‐STEP61 Signaling." Journal of Neurochemistry, vol. 166, no. 2, 2023, pp. 215-232, https://doi.org/10.1111/jnc.15874.